Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
BioCryst participates in a conference call with JPMorgan » 13:25
06/23/21
06/23
13:25
06/23/21
13:25
BCRX

BioCryst

$16.92 /

+0.28 (+1.68%)

Conference call with CEO…

Conference call with CEO Stonehouse, CMO Sheridan and CCO Gayer will be held on June 23 at 2 pm. Webcast Link

ShowHide Related Items >><<
BCRX BioCryst
$16.92 /

+0.28 (+1.68%)

BCRX BioCryst
$16.92 /

+0.28 (+1.68%)

06/17/21 Cowen
BioCryst price target raised to $21 from $18 at Cowen
05/28/21 Piper Sandler
BioCryst price target raised to $18 from $15 at Piper Sandler
05/07/21 Barclays
BioCryst price target raised to $20 from $13 at Barclays
05/06/21 Evercore ISI
BioCryst price target raised to $20 from $16 at Evercore ISI
BCRX BioCryst
$16.92 /

+0.28 (+1.68%)

BCRX BioCryst
$16.92 /

+0.28 (+1.68%)

BCRX BioCryst
$16.92 /

+0.28 (+1.68%)

BCRX BioCryst
$16.92 /

+0.28 (+1.68%)

Conference/Events
BioCryst participates in a conference call with JPMorgan » 10:31
06/23/21
06/23
10:31
06/23/21
10:31
BCRX

BioCryst

$17.24 /

+0.6 (+3.61%)

Conference call with CEO…

Conference call with CEO Stonehouse, CMO Sheridan and CCO Gayer will be held on June 23 at 2 pm. Webcast Link

ShowHide Related Items >><<
BCRX BioCryst
$17.24 /

+0.6 (+3.61%)

BCRX BioCryst
$17.24 /

+0.6 (+3.61%)

06/17/21 Cowen
BioCryst price target raised to $21 from $18 at Cowen
05/28/21 Piper Sandler
BioCryst price target raised to $18 from $15 at Piper Sandler
05/07/21 Barclays
BioCryst price target raised to $20 from $13 at Barclays
05/06/21 Evercore ISI
BioCryst price target raised to $20 from $16 at Evercore ISI
BCRX BioCryst
$17.24 /

+0.6 (+3.61%)

BCRX BioCryst
$17.24 /

+0.6 (+3.61%)

BCRX BioCryst
$17.24 /

+0.6 (+3.61%)

BCRX BioCryst
$17.24 /

+0.6 (+3.61%)

Over a week ago
Recommendations
BioCryst price target raised to $21 from $18 at Cowen » 08:12
06/17/21
06/17
08:12
06/17/21
08:12
BCRX

BioCryst

$16.08 /

+0.475 (+3.04%)

Cowen analyst Ken…

Cowen analyst Ken Cacciatore raised the firm's price target on BioCryst to $21 from $18 and keeps an Outperform rating on the shares. The analyst called it a Best Smidcap idea with his thesis justified on Orladeyo alone and the pipeline could meaningfully add to it.

ShowHide Related Items >><<
BCRX BioCryst
$16.08 /

+0.475 (+3.04%)

BCRX BioCryst
$16.08 /

+0.475 (+3.04%)

05/28/21 Piper Sandler
BioCryst price target raised to $18 from $15 at Piper Sandler
05/07/21 Barclays
BioCryst price target raised to $20 from $13 at Barclays
05/06/21 Evercore ISI
BioCryst price target raised to $20 from $16 at Evercore ISI
04/30/21 JMP Securities
JMP Securities reiterates Outperform on BioCryst after Orladeyo's EU approval
BCRX BioCryst
$16.08 /

+0.475 (+3.04%)

BCRX BioCryst
$16.08 /

+0.475 (+3.04%)

BCRX BioCryst
$16.08 /

+0.475 (+3.04%)

BCRX BioCryst
$16.08 /

+0.475 (+3.04%)

Hot Stocks
BioCryst announces acceptance, accelerated review of ORLADEYO in Israel » 07:05
06/16/21
06/16
07:05
06/16/21
07:05
BCRX

BioCryst

$15.60 /

-0.665 (-4.09%)

BioCryst Pharmaceuticals…

BioCryst Pharmaceuticals announced that the Israeli Ministry of Health has accepted the regulatory submission of ORLADEYO for the prevention of recurrent attacks in patients with hereditary angioedema 12 years and older. The Israeli Ministry of Health also has granted an accelerated review. In addition, BioCryst has entered into a distribution and supply agreement granting Neopharm, a corporation organized under the laws of the State of Israel, the exclusive rights to commercialize ORLADEYO in Israel.

ShowHide Related Items >><<
BCRX BioCryst
$15.60 /

-0.665 (-4.09%)

BCRX BioCryst
$15.60 /

-0.665 (-4.09%)

05/28/21 Piper Sandler
BioCryst price target raised to $18 from $15 at Piper Sandler
05/07/21 Barclays
BioCryst price target raised to $20 from $13 at Barclays
05/06/21 Evercore ISI
BioCryst price target raised to $20 from $16 at Evercore ISI
04/30/21 JMP Securities
JMP Securities reiterates Outperform on BioCryst after Orladeyo's EU approval
BCRX BioCryst
$15.60 /

-0.665 (-4.09%)

BCRX BioCryst
$15.60 /

-0.665 (-4.09%)

BCRX BioCryst
$15.60 /

-0.665 (-4.09%)

BCRX BioCryst
$15.60 /

-0.665 (-4.09%)

Options
BioCryst call volume above normal and directionally bullish » 12:05
06/15/21
06/15
12:05
06/15/21
12:05
BCRX

BioCryst

$15.62 /

-0.645 (-3.97%)

Bullish option flow…

Bullish option flow detected in BioCryst with 7,808 calls trading, 1.1x expected, and implied vol increasing over 2 points to 76.37%. Sep-21 20 calls and Jun-21 16 puts are the most active options, with total volume in those strikes near 2,900 contracts. The Put/Call Ratio is 0.28. Earnings are expected on August 5th.

ShowHide Related Items >><<
BCRX BioCryst
$15.62 /

-0.645 (-3.97%)

BCRX BioCryst
$15.62 /

-0.645 (-3.97%)

05/28/21 Piper Sandler
BioCryst price target raised to $18 from $15 at Piper Sandler
05/07/21 Barclays
BioCryst price target raised to $20 from $13 at Barclays
05/06/21 Evercore ISI
BioCryst price target raised to $20 from $16 at Evercore ISI
04/30/21 JMP Securities
JMP Securities reiterates Outperform on BioCryst after Orladeyo's EU approval
BCRX BioCryst
$15.62 /

-0.645 (-3.97%)

BCRX BioCryst
$15.62 /

-0.645 (-3.97%)

BCRX BioCryst
$15.62 /

-0.645 (-3.97%)

BCRX BioCryst
$15.62 /

-0.645 (-3.97%)

Hot Stocks
BioCryst launches ORLADEYO in Germany » 07:16
06/03/21
06/03
07:16
06/03/21
07:16
BCRX

BioCryst

$16.31 /

+0.37 (+2.32%)

BioCryst Pharmaceuticals…

BioCryst Pharmaceuticals announced that oral, once-daily ORLADEYO is now available for patients with a prescription in Germany. ORLADEYO was approved by the European Medicines Agency on April 30, 2021 for the prevention of recurrent hereditary angioedema attacks in HAE patients 12 years and older.

ShowHide Related Items >><<
BCRX BioCryst
$16.31 /

+0.37 (+2.32%)

BCRX BioCryst
$16.31 /

+0.37 (+2.32%)

05/28/21 Piper Sandler
BioCryst price target raised to $18 from $15 at Piper Sandler
05/07/21 Barclays
BioCryst price target raised to $20 from $13 at Barclays
05/06/21 Evercore ISI
BioCryst price target raised to $20 from $16 at Evercore ISI
04/30/21 JMP Securities
JMP Securities reiterates Outperform on BioCryst after Orladeyo's EU approval
BCRX BioCryst
$16.31 /

+0.37 (+2.32%)

BCRX BioCryst
$16.31 /

+0.37 (+2.32%)

BCRX BioCryst
$16.31 /

+0.37 (+2.32%)

BCRX BioCryst
$16.31 /

+0.37 (+2.32%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:12
05/28/21
05/28
12:12
05/28/21
12:12
CRM

Salesforce

$239.40 /

+13.68 (+6.06%)

, AAPL

Apple

$125.23 /

-0.1 (-0.08%)

, MSFT

Microsoft

$251.66 /

+2.26 (+0.91%)

, SWI

SolarWinds

$16.74 /

+0.07 (+0.42%)

, PFE

Pfizer

$38.88 /

+0.28 (+0.73%)

, BNTX

BioNTech

$203.50 /

+5.9 (+2.99%)

, NKLA

Nikola

$15.52 /

+0.005 (+0.03%)

, RIDE

Lordstown Motors

$10.40 /

-0.095 (-0.91%)

, PINC

Premier

$32.97 /

-1.47 (-4.27%)

, DXCM

DexCom

$376.21 /

+13.75 (+3.79%)

, BOX

Box

$23.19 /

+0.33 (+1.44%)

, PRVB

Provention Bio

$8.04 /

-2.63 (-24.65%)

, AMC

AMC Entertainment

$27.30 /

+0.6 (+2.25%)

, BA

Boeing

$246.16 /

-4.62 (-1.84%)

, JNJ

Johnson & Johnson

$170.18 /

+1.18 (+0.70%)

, WBT

Welbilt

$24.03 /

+4.13 (+20.75%)

, MIDD

Middleby

$163.88 /

-3.58 (-2.14%)

, XOM

Exxon Mobil

$58.17 /

-0.37 (-0.63%)

, HEXO

Hexo

$7.05 /

+0.51 (+7.80%)

, PLTR

Palantir

$23.13 /

+0.435 (+1.92%)

, BCRX

BioCryst

$15.42 /

+0.66 (+4.47%)

, GPS

Gap

$33.30 /

-1.88 (-5.34%)

, SLCA

U.S. Silica

$10.27 /

-2.115 (-17.08%)

, YEXT

Yext

$14.59 /

+2.285 (+18.57%)

, OLLI

Ollie's Bargain Outlet

$88.66 /

+8.245 (+10.25%)

, ULTA

Ulta Beauty

$346.50 /

+17.6 (+5.35%)

, HPQ

HP Inc.

$29.49 /

-2.55 (-7.96%)

, GES

Guess

$29.02 /

-1.78 (-5.78%)

, EBS

Emergent BioSolutions

$60.10 /

+2.29 (+3.96%)

Get caught up quickly on…

ShowHide Related Items >><<
YEXT Yext
$14.59 /

+2.285 (+18.57%)

XOM Exxon Mobil
$58.17 /

-0.37 (-0.63%)

WBT Welbilt
$24.03 /

+4.13 (+20.75%)

ULTA Ulta Beauty
$346.50 /

+17.6 (+5.35%)

SWI SolarWinds
$16.74 /

+0.07 (+0.42%)

SLCA U.S. Silica
$10.27 /

-2.115 (-17.08%)

RIDE Lordstown Motors
$10.40 /

-0.095 (-0.91%)

PRVB Provention Bio
$8.04 /

-2.63 (-24.65%)

PLTR Palantir
$23.13 /

+0.435 (+1.92%)

PINC Premier
$32.97 /

-1.47 (-4.27%)

PFE Pfizer
$38.88 /

+0.28 (+0.73%)

OLLI Ollie's Bargain Outlet
$88.66 /

+8.245 (+10.25%)

NKLA Nikola
$15.52 /

+0.005 (+0.03%)

MSFT Microsoft
$251.66 /

+2.26 (+0.91%)

MIDD Middleby
$163.88 /

-3.58 (-2.14%)

JNJ Johnson & Johnson
$170.18 /

+1.18 (+0.70%)

HPQ HP Inc.
$29.49 /

-2.55 (-7.96%)

HEXO Hexo
$7.05 /

+0.51 (+7.80%)

GPS Gap
$33.30 /

-1.88 (-5.34%)

GES Guess
$29.02 /

-1.78 (-5.78%)

EBS Emergent BioSolutions
$60.10 /

+2.29 (+3.96%)

DXCM DexCom
$376.21 /

+13.75 (+3.79%)

CRM Salesforce
$239.40 /

+13.68 (+6.06%)

BOX Box
$23.19 /

+0.33 (+1.44%)

BNTX BioNTech
$203.50 /

+5.9 (+2.99%)

BCRX BioCryst
$15.42 /

+0.66 (+4.47%)

BA Boeing
$246.16 /

-4.62 (-1.84%)

AMC AMC Entertainment
$27.30 /

+0.6 (+2.25%)

AAPL Apple
$125.23 /

-0.1 (-0.08%)

CRM Salesforce
$239.40 /

+13.68 (+6.06%)

05/28/21 Summit Insights
Salesforce results supportive for ServiceNow, LivePerson, says Summit Insights
05/28/21 RBC Capital
Salesforce price target raised to $290 from $285 at RBC Capital
05/28/21 Monness Crespi
Salesforce price target raised to $290 from $275 at Monness Crespi
05/28/21 Loop Capital
Salesforce price target raised to $235 from $225 at Loop Capital
AAPL Apple
$125.23 /

-0.1 (-0.08%)

05/28/21
Fly Intel: Top five analyst downgrades
05/28/21 New Street
New Street cuts Apple to Sell ahead of expected 12S 'downcycle'
05/28/21 New Street
Apple downgraded to Sell from Neutral at New Street
05/24/21 Craig-Hallum
Craig-Hallum bullish on Jamf Holding, initiates with a Buy
MSFT Microsoft
$251.66 /

+2.26 (+0.91%)

05/27/21 UBS
Zoom Video initiated with a Neutral at UBS
05/26/21 Wedbush
Microsoft cloud story not slowing down, says Wedbush
05/18/21 Jefferies
Microsoft price target lowered to $290 from $300 at Jefferies
05/12/21 Rosenblatt
Microsoft initiated with a Buy at Rosenblatt
SWI SolarWinds
$16.74 /

+0.07 (+0.42%)

05/14/21 Goldman Sachs
SolarWinds initiated with a Sell at Goldman Sachs
03/15/21 Credit Suisse
SolarWinds assumed with a Neutral at Credit Suisse
03/03/21 Citi
SolarWinds assumed with a Buy at Citi
02/23/21 Truist
Palo Alto Networks price target raised to $425 from $385 at Truist
PFE Pfizer
$38.88 /

+0.28 (+0.73%)

05/18/21 William Blair
William Blair says continued lack of '9001 safety signals positive for Sarepta
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
05/11/21 SVB Leerink
BioNTech price target raised to $159 from $118 at SVB Leerink
05/10/21 Morgan Stanley
Pfizer price target raised to $42 from $38 at Morgan Stanley
BNTX BioNTech
$203.50 /

+5.9 (+2.99%)

05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
05/11/21
Fly Intel: Top five analyst downgrades
NKLA Nikola
$15.52 /

+0.005 (+0.03%)

05/28/21
Fly Intel: Top five analyst initiations
05/27/21 BTIG
Nikola initiated with a Buy at BTIG
05/10/21 Deutsche Bank
Nikola price target lowered to $16 from $19 at Deutsche Bank
04/19/21 Wedbush
Nikola price target lowered to $13 from $25 at Wedbush
RIDE Lordstown Motors
$10.40 /

-0.095 (-0.91%)

05/28/21 Deutsche Bank
Deutsche starts Lordstown with Hold on 'considerable uncertainty'
05/28/21 Deutsche Bank
Lordstown Motors initiated with a Hold at Deutsche Bank
05/25/21 Goldman Sachs
Lordstown Motors price target lowered to $8 from $10 at Goldman Sachs
PINC Premier
$32.97 /

-1.47 (-4.27%)

05/28/21 Barclays
Barclays double downgrades Premier with multiple expansion less likely
05/28/21 Barclays
Premier downgraded to Underweight from Overweight at Barclays
05/04/21 Piper Sandler
Premier price target lowered to $31 from $36 at Piper Sandler
DXCM DexCom
$376.21 /

+13.75 (+3.79%)

05/28/21
Fly Intel: Top five analyst upgrades
05/28/21 Wells Fargo
DexCom upgraded to Equal Weight from Underweight at Wells Fargo
05/28/21 Wells Fargo
DexCom upgraded to Equal Weight from Underweight at Wells Fargo
05/27/21 Piper Sandler
Medtronic price target raised to $140 from $130 at Piper Sandler
BOX Box
$23.19 /

+0.33 (+1.44%)

04/09/21 DA Davidson
Box price target lowered to $22 from $25 at DA Davidson
04/09/21 William Blair
KKR investment 'strong vote of confidence' in Box, says William Blair
04/09/21 William Blair
KKR investment 'strong vote of confidence' in Box, says William Blair
03/23/21 KeyBanc
Box price target raised to $27 from $22 at KeyBanc
PRVB Provention Bio
$8.04 /

-2.63 (-24.65%)

05/28/21 Chardan
Provention Bio price target lowered to $22.50 from $35 at Chardan
05/25/21 SVB Leerink
Provention Bio briefing documents a positive, says SVB Leerink
05/07/21 Cantor Fitzgerald
Provention Bio price target lowered to $19 from $25 at Cantor Fitzgerald
04/12/21 Chardan
Provention Bio price target lowered to $22.50 from $35 at Chardan
AMC AMC Entertainment
$27.30 /

+0.6 (+2.25%)

05/26/21
Fly Intel: Top five analyst downgrades
05/26/21 B. Riley
AMC Entertainment downgraded to Neutral from Buy at B. Riley
05/25/21 Citi
Citi boosts AMC target to $3.70, says shares remain overvalued
05/14/21 B. Riley
AMC Entertainment price target raised to $16 from $13 at B. Riley
BA Boeing
$246.16 /

-4.62 (-1.84%)

05/21/21 Citi
Boeing price target raised to $240 from $200 at Citi
05/12/21 Wells Fargo
Summer travel should be catalyst for commercial aero, says Wells Fargo
05/12/21 Wells Fargo
Boeing initiated with an Equal Weight at Wells Fargo
05/11/21 Morgan Stanley
Morgan Stanley says Boeing dip a 'particularly attractive buying opportunity'
JNJ Johnson & Johnson
$170.18 /

+1.18 (+0.70%)

05/28/21 Morgan Stanley
Johnson & Johnson assumed with an Overweight at Morgan Stanley
05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
WBT Welbilt
$24.03 /

+4.13 (+20.75%)

05/10/21 BMO Capital
Welbilt price target raised to $25 from $17 at BMO Capital
05/06/21 Baird
Welbilt price target raised to $26 from $18 at Baird
04/22/21
Fly Intel: Top five analyst downgrades
04/22/21 Jefferies
Middleby price target raised to $220 from $190 at Jefferies
MIDD Middleby
$163.88 /

-3.58 (-2.14%)

05/10/21 BMO Capital
Middleby price target raised to $250 from $225 at BMO Capital
05/06/21 Baird
Middleby price target raised to $214 from $195 at Baird
XOM Exxon Mobil
$58.17 /

-0.37 (-0.63%)

05/17/21 Mizuho
Exxon Mobil price target raised to $66 from $58 at Mizuho
05/05/21 DZ Bank
Exxon Mobil upgraded to Buy from Hold at DZ Bank
05/03/21 Truist
Exxon Mobil price target raised to $64 from $60 at Truist
05/03/21 Mizuho
Exxon Mobil price target raised to $58 from $55 at Mizuho
HEXO Hexo
$7.05 /

+0.51 (+7.80%)

03/22/21 Desjardins
Hexo price target raised to C$8 from C$5.40 at Desjardins
03/22/21 BMO Capital
Hexo upgraded to Outperform from Market Perform at BMO Capital
03/19/21 CIBC
Hexo price target lowered to C$13 from C$13.50 at CIBC
02/18/21 Canaccord
Hexo price target raised to C$8 from C$5 at Canaccord
PLTR Palantir
$23.13 /

+0.435 (+1.92%)

05/12/21 Wolfe Research
Palantir price target lowered to $20 from $23 at Wolfe Research
05/12/21 Morgan Stanley
Palantir building toward more durable growth, but priced in, says Morgan Stanley
05/12/21 Goldman Sachs
Goldman 'encouraged' by 'noteworthy' Q1 from Palantir, keeps Buy
05/12/21 Citi
Palantir price target raised to $17 from $15 at Citi
BCRX BioCryst
$15.42 /

+0.66 (+4.47%)

05/28/21 Piper Sandler
BioCryst price target raised to $18 from $15 at Piper Sandler
05/07/21 Barclays
BioCryst price target raised to $20 from $13 at Barclays
05/06/21 Evercore ISI
BioCryst price target raised to $20 from $16 at Evercore ISI
04/30/21 JMP Securities
JMP Securities reiterates Outperform on BioCryst after Orladeyo's EU approval
GPS Gap
$33.30 /

-1.88 (-5.34%)

05/28/21 RBC Capital
Gap price target raised to $40 from $33 at RBC Capital
05/28/21 B. Riley
Gap price target raised to $35 from $34 at B. Riley
05/28/21 MKM Partners
Gap price target raised to $34 from $29 at MKM Partners
05/25/21 Morgan Stanley
Gap price target raised to $33 ahead of earnings at Morgan Stanley
SLCA U.S. Silica
$10.27 /

-2.115 (-17.08%)

05/28/21 Barclays
U.S. Silica downgraded to Underweight from Equal Weight at Barclays
05/11/21 Barclays
U.S. Silica price target raised to $12 from $3 at Barclays
03/02/21 B. Riley
U.S. Silica price target raised to $15 from $4.35 at B. Riley Securities
01/04/21 Evercore ISI
U.S. Silica upgraded to Outperform from In Line at Evercore ISI
YEXT Yext
$14.59 /

+2.285 (+18.57%)

03/04/21
Fly Intel: Top five analyst downgrades
03/04/21 Truist
Yext price target lowered to $17 from $23 at Truist
03/04/21 William Blair
Yext downgraded to Market Perform on growth headwinds at William Blair
03/04/21 William Blair
Yext downgraded to Market Perform from Outperform at William Blair
OLLI Ollie's Bargain Outlet
$88.66 /

+8.245 (+10.25%)

05/28/21 Piper Sandler
Ollie's Bargain Outlet price target raised to $112 from $107 at Piper Sandler
05/24/21
Fly Intel: Top five analyst upgrades
05/24/21 Morgan Stanley
Ollie's upgraded to Equal Weight from Underweight at Morgan Stanley
05/17/21 JPMorgan
Ollie's Bargain Outlet price target lowered to $95 from $109 at JPMorgan
ULTA Ulta Beauty
$346.50 /

+17.6 (+5.35%)

05/28/21 DA Davidson
Ulta Beauty price target raised to $376 from $361 at DA Davidson
05/28/21 Loop Capital
Ulta Beauty price target raised to $340 from $320 at Loop Capital
05/28/21 Stifel
Ulta Beauty price target raised to $330 from $285 at Stifel
05/28/21 JPMorgan
Ulta Beauty price target raised to $379 from $357 at JPMorgan
HPQ HP Inc.
$29.49 /

-2.55 (-7.96%)

05/28/21 Morgan Stanley
HP Inc. post-earnings pullback a buying opportunity, says Morgan Stanley
05/28/21 Citi
Citi says HP is not at peak, reiterates Buy rating
05/28/21 Deutsche Bank
HP Inc. price target raised to $32 from $30 at Deutsche Bank
05/28/21 Citi
Lenovo, HP, Dell earnings good news for Intel and AMD, says Citi
GES Guess
$29.02 /

-1.78 (-5.78%)

05/28/21 B. Riley
Guess price target raised to $38 from $33 at B. Riley
05/19/21 B. Riley
Guess price target raised to $33 from $29 at B. Riley
04/01/21 B. Riley
Guess price target raised to $29 from $27 at B. Riley Securities
01/12/21 B. Riley
Guess price target raised to $27 from $20 at B. Riley Securities
EBS Emergent BioSolutions
$60.10 /

+2.29 (+3.96%)

05/05/21 Wells Fargo
Emergent BioSolutions price target lowered to $64 from $70 at Wells Fargo
05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/30/21 Chardan
Emergent BioSolutions price target lowered to $92 from $112 at Chardan
YEXT Yext
$14.59 /

+2.285 (+18.57%)

XOM Exxon Mobil
$58.17 /

-0.37 (-0.63%)

WBT Welbilt
$24.03 /

+4.13 (+20.75%)

ULTA Ulta Beauty
$346.50 /

+17.6 (+5.35%)

SWI SolarWinds
$16.74 /

+0.07 (+0.42%)

SLCA U.S. Silica
$10.27 /

-2.115 (-17.08%)

RIDE Lordstown Motors
$10.40 /

-0.095 (-0.91%)

PRVB Provention Bio
$8.04 /

-2.63 (-24.65%)

PLTR Palantir
$23.13 /

+0.435 (+1.92%)

PINC Premier
$32.97 /

-1.47 (-4.27%)

PFE Pfizer
$38.88 /

+0.28 (+0.73%)

OLLI Ollie's Bargain Outlet
$88.66 /

+8.245 (+10.25%)

NKLA Nikola
$15.52 /

+0.005 (+0.03%)

MSFT Microsoft
$251.66 /

+2.26 (+0.91%)

MIDD Middleby
$163.88 /

-3.58 (-2.14%)

JNJ Johnson & Johnson
$170.18 /

+1.18 (+0.70%)

HPQ HP Inc.
$29.49 /

-2.55 (-7.96%)

HEXO Hexo
$7.05 /

+0.51 (+7.80%)

GPS Gap
$33.30 /

-1.88 (-5.34%)

GES Guess
$29.02 /

-1.78 (-5.78%)

EBS Emergent BioSolutions
$60.10 /

+2.29 (+3.96%)

DXCM DexCom
$376.21 /

+13.75 (+3.79%)

CRM Salesforce
$239.40 /

+13.68 (+6.06%)

BOX Box
$23.19 /

+0.33 (+1.44%)

BNTX BioNTech
$203.50 /

+5.9 (+2.99%)

BCRX BioCryst
$15.42 /

+0.66 (+4.47%)

BA Boeing
$246.16 /

-4.62 (-1.84%)

AMC AMC Entertainment
$27.30 /

+0.6 (+2.25%)

AAPL Apple
$125.23 /

-0.1 (-0.08%)

  • 14
    Jan
  • 23
    Jul
  • 18
    Jun
XOM Exxon Mobil
$58.17 /

-0.37 (-0.63%)

WBT Welbilt
$24.03 /

+4.13 (+20.75%)

SWI SolarWinds
$16.74 /

+0.07 (+0.42%)

RIDE Lordstown Motors
$10.40 /

-0.095 (-0.91%)

PLTR Palantir
$23.13 /

+0.435 (+1.92%)

PFE Pfizer
$38.88 /

+0.28 (+0.73%)

NKLA Nikola
$15.52 /

+0.005 (+0.03%)

MSFT Microsoft
$251.66 /

+2.26 (+0.91%)

JNJ Johnson & Johnson
$170.18 /

+1.18 (+0.70%)

HPQ HP Inc.
$29.49 /

-2.55 (-7.96%)

GPS Gap
$33.30 /

-1.88 (-5.34%)

EBS Emergent BioSolutions
$60.10 /

+2.29 (+3.96%)

DXCM DexCom
$376.21 /

+13.75 (+3.79%)

CRM Salesforce
$239.40 /

+13.68 (+6.06%)

BOX Box
$23.19 /

+0.33 (+1.44%)

BCRX BioCryst
$15.42 /

+0.66 (+4.47%)

BA Boeing
$246.16 /

-4.62 (-1.84%)

AMC AMC Entertainment
$27.30 /

+0.6 (+2.25%)

AAPL Apple
$125.23 /

-0.1 (-0.08%)

YEXT Yext
$14.59 /

+2.285 (+18.57%)

XOM Exxon Mobil
$58.17 /

-0.37 (-0.63%)

WBT Welbilt
$24.03 /

+4.13 (+20.75%)

ULTA Ulta Beauty
$346.50 /

+17.6 (+5.35%)

SWI SolarWinds
$16.74 /

+0.07 (+0.42%)

SLCA U.S. Silica
$10.27 /

-2.115 (-17.08%)

RIDE Lordstown Motors
$10.40 /

-0.095 (-0.91%)

PRVB Provention Bio
$8.04 /

-2.63 (-24.65%)

PLTR Palantir
$23.13 /

+0.435 (+1.92%)

PFE Pfizer
$38.88 /

+0.28 (+0.73%)

OLLI Ollie's Bargain Outlet
$88.66 /

+8.245 (+10.25%)

NKLA Nikola
$15.52 /

+0.005 (+0.03%)

MSFT Microsoft
$251.66 /

+2.26 (+0.91%)

HEXO Hexo
$7.05 /

+0.51 (+7.80%)

GPS Gap
$33.30 /

-1.88 (-5.34%)

GES Guess
$29.02 /

-1.78 (-5.78%)

EBS Emergent BioSolutions
$60.10 /

+2.29 (+3.96%)

DXCM DexCom
$376.21 /

+13.75 (+3.79%)

CRM Salesforce
$239.40 /

+13.68 (+6.06%)

BOX Box
$23.19 /

+0.33 (+1.44%)

BCRX BioCryst
$15.42 /

+0.66 (+4.47%)

BA Boeing
$246.16 /

-4.62 (-1.84%)

AMC AMC Entertainment
$27.30 /

+0.6 (+2.25%)

AAPL Apple
$125.23 /

-0.1 (-0.08%)

XOM Exxon Mobil
$58.17 /

-0.37 (-0.63%)

WBT Welbilt
$24.03 /

+4.13 (+20.75%)

ULTA Ulta Beauty
$346.50 /

+17.6 (+5.35%)

RIDE Lordstown Motors
$10.40 /

-0.095 (-0.91%)

PRVB Provention Bio
$8.04 /

-2.63 (-24.65%)

PLTR Palantir
$23.13 /

+0.435 (+1.92%)

PFE Pfizer
$38.88 /

+0.28 (+0.73%)

NKLA Nikola
$15.52 /

+0.005 (+0.03%)

MSFT Microsoft
$251.66 /

+2.26 (+0.91%)

JNJ Johnson & Johnson
$170.18 /

+1.18 (+0.70%)

HPQ HP Inc.
$29.49 /

-2.55 (-7.96%)

HEXO Hexo
$7.05 /

+0.51 (+7.80%)

GPS Gap
$33.30 /

-1.88 (-5.34%)

GES Guess
$29.02 /

-1.78 (-5.78%)

CRM Salesforce
$239.40 /

+13.68 (+6.06%)

BOX Box
$23.19 /

+0.33 (+1.44%)

BNTX BioNTech
$203.50 /

+5.9 (+2.99%)

BCRX BioCryst
$15.42 /

+0.66 (+4.47%)

BA Boeing
$246.16 /

-4.62 (-1.84%)

AMC AMC Entertainment
$27.30 /

+0.6 (+2.25%)

AAPL Apple
$125.23 /

-0.1 (-0.08%)

Recommendations
BioCryst price target raised to $18 from $15 at Piper Sandler » 04:51
05/28/21
05/28
04:51
05/28/21
04:51
BCRX

BioCryst

$14.76 /

+1.16 (+8.53%)

Piper Sandler analyst…

Piper Sandler analyst Christopher Raymond raised the firm's price target on BioCryst to $18 from $15 and keeps an Overweight rating on the shares after taking over coverage of the name. The shares "can continue to work if Orladeyo continues to put up numbers," Raymond tells investors in a research note. The analyst likes the setup of BioCryst.

ShowHide Related Items >><<
BCRX BioCryst
$14.76 /

+1.16 (+8.53%)

BCRX BioCryst
$14.76 /

+1.16 (+8.53%)

05/07/21 Barclays
BioCryst price target raised to $20 from $13 at Barclays
05/06/21 Evercore ISI
BioCryst price target raised to $20 from $16 at Evercore ISI
04/30/21 JMP Securities
JMP Securities reiterates Outperform on BioCryst after Orladeyo's EU approval
03/24/21 H.C. Wainwright
BioCryst price target raised to $19 from $14 at H.C. Wainwright
BCRX BioCryst
$14.76 /

+1.16 (+8.53%)

BCRX BioCryst
$14.76 /

+1.16 (+8.53%)

BCRX BioCryst
$14.76 /

+1.16 (+8.53%)

BCRX BioCryst
$14.76 /

+1.16 (+8.53%)

Over a month ago
Options
BioCryst call volume above normal and directionally bullish » 14:05
05/17/21
05/17
14:05
05/17/21
14:05
BCRX

BioCryst

$14.09 /

+1.25 (+9.74%)

Bullish option flow…

Bullish option flow detected in BioCryst with 19,325 calls trading, 3x expected, and implied vol increasing over 3 points to 80.64%. May-21 14 calls and May-21 15 calls are the most active options, with total volume in those strikes near 6,900 contracts. The Put/Call Ratio is 0.27. Earnings are expected on August 5th.

ShowHide Related Items >><<
BCRX BioCryst
$14.09 /

+1.25 (+9.74%)

BCRX BioCryst
$14.09 /

+1.25 (+9.74%)

05/07/21 Barclays
BioCryst price target raised to $20 from $13 at Barclays
05/06/21 Evercore ISI
BioCryst price target raised to $20 from $16 at Evercore ISI
04/30/21 JMP Securities
JMP Securities reiterates Outperform on BioCryst after Orladeyo's EU approval
03/24/21 H.C. Wainwright
BioCryst price target raised to $19 from $14 at H.C. Wainwright
BCRX BioCryst
$14.09 /

+1.25 (+9.74%)

  • 28
    May
BCRX BioCryst
$14.09 /

+1.25 (+9.74%)

BCRX BioCryst
$14.09 /

+1.25 (+9.74%)

BCRX BioCryst
$14.09 /

+1.25 (+9.74%)

Hot Stocks
BioCryst receives UK approval of ORLADEYO therapy in HAE patients » 09:27
05/12/21
05/12
09:27
05/12/21
09:27
BCRX

BioCryst

$12.14 /

+0.21 (+1.76%)

BioCryst Pharmaceuticals…

BioCryst Pharmaceuticals announced that the United Kingdom's Medicines and Healthcare products Regulatory Agency has granted marketing authorization for oral, once-daily ORLADEYO for the routine prevention of recurrent hereditary angioedema attacks in HAE patients 12 years and older. A decision from the National Institute for Health and Care Excellence and Scottish Medicines Consortium for use of ORLADEYO under the UK's National Health Service is anticipated in the fourth quarter of 2021.

ShowHide Related Items >><<
BCRX BioCryst
$12.14 /

+0.21 (+1.76%)

BCRX BioCryst
$12.14 /

+0.21 (+1.76%)

05/07/21 Barclays
BioCryst price target raised to $20 from $13 at Barclays
05/06/21 Evercore ISI
BioCryst price target raised to $20 from $16 at Evercore ISI
04/30/21 JMP Securities
JMP Securities reiterates Outperform on BioCryst after Orladeyo's EU approval
03/24/21 H.C. Wainwright
BioCryst price target raised to $19 from $14 at H.C. Wainwright
BCRX BioCryst
$12.14 /

+0.21 (+1.76%)

  • 28
    May
BCRX BioCryst
$12.14 /

+0.21 (+1.76%)

BCRX BioCryst
$12.14 /

+0.21 (+1.76%)

BCRX BioCryst
$12.14 /

+0.21 (+1.76%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.